Exchange: NYSE·Updated 07:49 PM EST

VSXY News

News
all
press releases
Victoria's Secret & Co. (VSXY) Hits Fresh High: Is There Still Room to Run?
Victoria's Secret (VSXY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
Victoria's Secret & Co. (VSXY) Hits Fresh High: Is There Still Room to Run?
Victoria's Secret (VSXY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks
More News
Life After AI: Where The Money Is Now Moving Submitted by QTR's Fringe FinanceAs I write this Thursday morning, Dow futures are green while Nasdaq futures are down roughly 0.5%. It's a small but interesting divergence, and one that supports something I've been predicting for a while...
Zero Hedge
a.k.a. Brands (AKA) delivered earnings and revenue surprises of -6.06% and -0.12%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Victoria's Secret (VSXY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks
According to The Fly, Wells Fargo raised its Victoria’s Secret price target to $120 from $100 and maintained an ‘Overweight’ rating.
Stocktwits
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
SHOO is poised for Q3 growth, supported by strong footwear demand, handbag momentum, DTC expansion and pricing gains despite rising cost pressures.
Zacks
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks
A healthcare AI collaboration and a bullish retail outlook lift sentiment, while a Phase 3 trial setback puts EyePoint under pressure.
Stocktwits

Advertisement|Remove ads.